Abstract
ABSTRACT: Clinical testing of growth hormone (GH) sufficiency is a controversial area in endocrinology. Due to the episodic nature of endogenous GH secretion, diagnosis of GH deficiency has been defined as a failure to achieve normal GH levels in response to at least two stimuli. This testing is associated with significant patient morbidity and cost. We analyzed our experience over a 4-y period to determine whether clinical or biochemical variables could be used to predict the results of a specific GH testing procedure. Of 180 cases analyzed (67% male, mean age 8.89 ± 4.39 y, range neonate-16 y), eight cases had incomplete GH testing results. Of the remaining 172, 19 were GH deficient (GH level <7 ng/mL). Younger age, higher body mass index and a greater degree of bone age delay were characteristic of the GH-deficient population; however, none of these variables alone was of diagnostic utility. Serum IGF-I level was below the normal range for 81% of the GH deficient and 47% of the GH-sufficient children; and was the only single variable that provided a reasonable between-group distinction. Discriminant analysis resulted in development of a new variable, based on IGF-I z scores, chronologic age, degree of bone age delay, and body mass index, which would have allowed exclusion of GH deficiency without provocative testing for 58% of the GH sufficient population, whereas permitting the diagnosis of GH deficiency for all GH-deficient subjects. Our data are dependent on the IGF-I assay method and the clinical definition for GH deficiency; therefore, the calculated predictive values are not applicable to all clinical populations. However, our data provide a new perspective on the integration of IGF-I levels and clinical information in predicting GH sufficiency.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, P., Wilson, D., Rountree, L. et al. Efficacy of Insulin-Like Growth Factor I Levels in Predicting the Response to Provocative Growth Hormone Testing. Pediatr Res 27, 45–51 (1990). https://doi.org/10.1203/00006450-199001000-00015
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199001000-00015
This article is cited by
-
Prospective investigation of anterior pituitary function in the acute phase and 12 months after pediatric traumatic brain injury
Child's Nervous System (2014)
-
Leitlinie zur Diagnostik des Wachstumshormonmangels im Kindes- und Jugendalter
Monatsschrift Kinderheilkunde (2009)
-
The role of insulin like growth factor (IGF) — 1 and IGF — binding protein-3 in diagnosis of Growth Hormone Deficiency in short stature children
The Indian Journal of Pediatrics (2009)
-
Selecting short-statured children needing growth hormone testing: Derivation and validation of a clinical decision rule
BMC Pediatrics (2008)
-
Growth hormone response to oral clonidine test in normal and short children
Journal of Endocrinological Investigation (1993)